Year: 2019
Type: editorial
Abstract: In the wake of reports that a Chinese biophysicist, He Jiankui, used a genome editing technology, CRISPR/Cas9, to modify the CCR5 gene in viable human embryos, the criticism from the international ...
Authors: Christopher Thomas Scott, Cynthia Selin
Institutions: Baylor College of Medicine, Arizona State University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2924419235
